Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis

Detalhes bibliográficos
Autor(a) principal: Corazza, B. J.M. [UNESP]
Data de Publicação: 2021
Outros Autores: Martinho, F. C., Khoury, R. D. [UNESP], Toia, C. C. [UNESP], Orozco, E. I.F. [UNESP], Prado, R. F. [UNESP], Machado, F. P. [UNESP], Valera, M. C. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1111/iej.13403
http://hdl.handle.net/11449/205252
Resumo: Aim: To investigate the presence of resolvins E1 (RvE1) and D2 (RvD2) in teeth with primary endodontic infections and apical periodontitis, and to assess the influence of calcium hydroxide medication [Ca(OH)2], in association with 2% chlorhexidine gel (2% CHX gel), and N-acetylcysteine (NAC) on the levels of RvE1 and RvD2 in periapical tissues. Methodology: Thirty-six single-rooted teeth with primary endodontic infections and apical periodontitis were selected and randomly divided into three groups according to the medication: [Ca(OH)2] + saline solution (SSL) [Ca(OH)2 + SSL group] (n = 12), Ca(OH)2 + 2% chlorhexidine gel [Ca(OH)2 + 2% CHX gel group] (n = 12) and NAC [NAC group] (n = 12). Samples were collected from the periapical interstitial fluid at two different sampling times: before (S1) and after 14 days of intracanal medications (S2). Resolvins were measured using the enzyme-linked immunosorbent assay. Data were analysed using paired t-test, Wilcoxon test and Kruskal–Wallis test, followed by Dunn’s post hoc test; all statistical tests were performed at a significance level of 5%. Results: RvE1 and RvD2 were detected in 100% of the samples (36/36) at S1 and S2. Ca(OH)2 medication did not increase the levels of RvE1 or RvD2 (both P > 0.05); however, NAC significantly increased the levels of RvE1 and RvD2 after 14 days of treatment (P < 0.05). Conclusions: RvE1 and RvD2 were detected in periapical tissues from teeth with root canal infections. Moreover, calcium hydroxide medication did not increase the levels of resolvins in apical periodontitis. In contrast, the use of NAC intracanal medication significantly increased the levels of RvE1 and RvD2 after 14 days of treatment.
id UNSP_857188c827826b86c2670b80b41e4932
oai_identifier_str oai:repositorio.unesp.br:11449/205252
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitiscalcium hydroxideintracanal medicationresolvinsroot canalAim: To investigate the presence of resolvins E1 (RvE1) and D2 (RvD2) in teeth with primary endodontic infections and apical periodontitis, and to assess the influence of calcium hydroxide medication [Ca(OH)2], in association with 2% chlorhexidine gel (2% CHX gel), and N-acetylcysteine (NAC) on the levels of RvE1 and RvD2 in periapical tissues. Methodology: Thirty-six single-rooted teeth with primary endodontic infections and apical periodontitis were selected and randomly divided into three groups according to the medication: [Ca(OH)2] + saline solution (SSL) [Ca(OH)2 + SSL group] (n = 12), Ca(OH)2 + 2% chlorhexidine gel [Ca(OH)2 + 2% CHX gel group] (n = 12) and NAC [NAC group] (n = 12). Samples were collected from the periapical interstitial fluid at two different sampling times: before (S1) and after 14 days of intracanal medications (S2). Resolvins were measured using the enzyme-linked immunosorbent assay. Data were analysed using paired t-test, Wilcoxon test and Kruskal–Wallis test, followed by Dunn’s post hoc test; all statistical tests were performed at a significance level of 5%. Results: RvE1 and RvD2 were detected in 100% of the samples (36/36) at S1 and S2. Ca(OH)2 medication did not increase the levels of RvE1 or RvD2 (both P > 0.05); however, NAC significantly increased the levels of RvE1 and RvD2 after 14 days of treatment (P < 0.05). Conclusions: RvE1 and RvD2 were detected in periapical tissues from teeth with root canal infections. Moreover, calcium hydroxide medication did not increase the levels of resolvins in apical periodontitis. In contrast, the use of NAC intracanal medication significantly increased the levels of RvE1 and RvD2 after 14 days of treatment.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Restorative Dentistry Endodontic Division Institute of Science and Technology São Paulo State University – UNESPDepartment of Advanced Oral Sciences and Therapeutics School of Dentistry University of MarylandDepartment of Restorative Dentistry Endodontic Division Institute of Science and Technology São Paulo State University – UNESPFAPESP: 2016/26012-3FAPESP: 2018/01703-9Universidade Estadual Paulista (Unesp)University of MarylandCorazza, B. J.M. [UNESP]Martinho, F. C.Khoury, R. D. [UNESP]Toia, C. C. [UNESP]Orozco, E. I.F. [UNESP]Prado, R. F. [UNESP]Machado, F. P. [UNESP]Valera, M. C. [UNESP]2021-06-25T10:12:18Z2021-06-25T10:12:18Z2021-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article61-73http://dx.doi.org/10.1111/iej.13403International Endodontic Journal, v. 54, n. 1, p. 61-73, 2021.1365-25910143-2885http://hdl.handle.net/11449/20525210.1111/iej.134032-s2.0-85092018945Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengInternational Endodontic Journalinfo:eu-repo/semantics/openAccess2021-10-23T12:23:59Zoai:repositorio.unesp.br:11449/205252Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-23T12:23:59Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
title Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
spellingShingle Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
Corazza, B. J.M. [UNESP]
calcium hydroxide
intracanal medication
resolvins
root canal
title_short Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
title_full Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
title_fullStr Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
title_full_unstemmed Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
title_sort Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis
author Corazza, B. J.M. [UNESP]
author_facet Corazza, B. J.M. [UNESP]
Martinho, F. C.
Khoury, R. D. [UNESP]
Toia, C. C. [UNESP]
Orozco, E. I.F. [UNESP]
Prado, R. F. [UNESP]
Machado, F. P. [UNESP]
Valera, M. C. [UNESP]
author_role author
author2 Martinho, F. C.
Khoury, R. D. [UNESP]
Toia, C. C. [UNESP]
Orozco, E. I.F. [UNESP]
Prado, R. F. [UNESP]
Machado, F. P. [UNESP]
Valera, M. C. [UNESP]
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
University of Maryland
dc.contributor.author.fl_str_mv Corazza, B. J.M. [UNESP]
Martinho, F. C.
Khoury, R. D. [UNESP]
Toia, C. C. [UNESP]
Orozco, E. I.F. [UNESP]
Prado, R. F. [UNESP]
Machado, F. P. [UNESP]
Valera, M. C. [UNESP]
dc.subject.por.fl_str_mv calcium hydroxide
intracanal medication
resolvins
root canal
topic calcium hydroxide
intracanal medication
resolvins
root canal
description Aim: To investigate the presence of resolvins E1 (RvE1) and D2 (RvD2) in teeth with primary endodontic infections and apical periodontitis, and to assess the influence of calcium hydroxide medication [Ca(OH)2], in association with 2% chlorhexidine gel (2% CHX gel), and N-acetylcysteine (NAC) on the levels of RvE1 and RvD2 in periapical tissues. Methodology: Thirty-six single-rooted teeth with primary endodontic infections and apical periodontitis were selected and randomly divided into three groups according to the medication: [Ca(OH)2] + saline solution (SSL) [Ca(OH)2 + SSL group] (n = 12), Ca(OH)2 + 2% chlorhexidine gel [Ca(OH)2 + 2% CHX gel group] (n = 12) and NAC [NAC group] (n = 12). Samples were collected from the periapical interstitial fluid at two different sampling times: before (S1) and after 14 days of intracanal medications (S2). Resolvins were measured using the enzyme-linked immunosorbent assay. Data were analysed using paired t-test, Wilcoxon test and Kruskal–Wallis test, followed by Dunn’s post hoc test; all statistical tests were performed at a significance level of 5%. Results: RvE1 and RvD2 were detected in 100% of the samples (36/36) at S1 and S2. Ca(OH)2 medication did not increase the levels of RvE1 or RvD2 (both P > 0.05); however, NAC significantly increased the levels of RvE1 and RvD2 after 14 days of treatment (P < 0.05). Conclusions: RvE1 and RvD2 were detected in periapical tissues from teeth with root canal infections. Moreover, calcium hydroxide medication did not increase the levels of resolvins in apical periodontitis. In contrast, the use of NAC intracanal medication significantly increased the levels of RvE1 and RvD2 after 14 days of treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-25T10:12:18Z
2021-06-25T10:12:18Z
2021-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1111/iej.13403
International Endodontic Journal, v. 54, n. 1, p. 61-73, 2021.
1365-2591
0143-2885
http://hdl.handle.net/11449/205252
10.1111/iej.13403
2-s2.0-85092018945
url http://dx.doi.org/10.1111/iej.13403
http://hdl.handle.net/11449/205252
identifier_str_mv International Endodontic Journal, v. 54, n. 1, p. 61-73, 2021.
1365-2591
0143-2885
10.1111/iej.13403
2-s2.0-85092018945
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv International Endodontic Journal
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 61-73
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799964896504315904